Medicure (MCUJF) Gains from Investment Securities (2009 - 2026)

Medicure's Gains from Investment Securities history runs 17 years deep, the most recent figure standing at $10208.9 for Q1 2026.

• In Q1 2026, Gains from Investment Securities fell 58.15% year-over-year to $10208.9; the TTM figure through Mar 2026 stood at $85224.2 (up 4.46% YoY), while the FY2022 annual figure was -$266131.5, up 81.5% from the prior year.
• Gains from Investment Securities for Q1 2026 stood at $10208.9, down from $15259.3 in the prior quarter.
• The five-year high for Gains from Investment Securities was $231557.4 in Q3 2022, with the low at $5194.8 in Q1 2024.
• The 5-year median for Gains from Investment Securities is $24392.1 (2025), against an average of $48103.9.
• The sharpest annual moves came in 2022 and 2023: Gains from Investment Securities soared 6544.75% in 2022, then plunged 83.09% in 2023.
• Medicure's Gains from Investment Securities stood at $32414.9 in 2022, then tumbled by 45.23% to $17752.7 in 2023, then surged by 89.95% to $33720.5 in 2024, then tumbled by 54.75% to $15259.3 in 2025, then tumbled by 33.1% to $10208.9 in 2026.
• Business Quant data shows MCUJF's Gains from Investment Securities at $10208.9 in Q1 2026, $15259.3 in Q3 2025, and $35363.9 in Q2 2025.